Skip to content

Clinical trials

Phase 2 Bone Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Neoplasms Phase: Phase 2 Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20041
20072
20082
20091
20102
20113
20121
20131
20152
20161
20171
20183
20193
20214
20222
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting7
Withdrawn6
Active, not recruiting4
Terminated3
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Brown University2
Hoffmann-La Roche2
Actuate Therapeutics Inc.1
Amgen1
Asan Medical Center1
Assaf-Harofeh Medical Center1
AstraZeneca1
Centre Leon Berard1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Neoplasms37
Sarcoma19
Osteosarcoma12
Neoplasm Metastasis7
Rhabdomyosarcoma6
Breast Neoplasms5
Chondrosarcoma5
Histiocytoma, Malignant Fibrous5
Sarcoma, Ewing5
Leiomyosarcoma4

Trials

Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.